Poster Abstract Session:
143. Clinical Trials
Friday, October 28, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Pediatric ID, Investigative ID, Adult ID

Presentations:
Efficacy and Safety of RBX2660 for the Prevention of Recurrent Clostridium difficile Infection: Results of the PUNCH CD 2 Trial
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA ; Christine Lee, MD ; Robert Orenstein, DO, FIDSA ; Sahil Khanna, MBBS, MS ; Gail Hecht, MD ; Joseph Fraiz, MD
Safety and Immunogenicity of Different Formulations of the Takeda Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial
Jakob Cramer, MD ; Frank Baehner, MD ; Paul Mendelman, MD ; Ralf Clemens, MD ; Astrid Borkowski, MD ; Geert Leroux-Roels, MD ; Pierre Van Damme, MD
Functional Antibody Responses to GEN-003, a Herpes Simplex Virus Immunotherapy that Durably Reduces Viral Shedding up to 12 Months Post Dosing
Lisa K. Mcneil, PhD ; Nicolle Siddall, BS ; Amy Baccari, BS ; Veronica Clemens, BS ; Johanna K. Kaufmann, PhD ; Shane Larson, MS ; Thomas Oliphant, MS, PhD ; Bin Zhang, PhD ; Jessica B. Flechtner, PhD ; Seth Hetherington, MD
Tedizolid for Treatment of Enterococcal Bacteremia
Praveen Sudhindra, MD ; Leslie Lee, PharmD ; Guiqing Wang, MD, PhD ; Abhay Dhand, MD
Effectiveness of High-Dose Influenza Vaccination on Hospitalizations of Older Adults in United States Nursing Homes: Results from a Cluster-Randomized Controlled Trial
Stefan Gravenstein, MD, MPH ; H. Edward Davidson, PharmD, MPH ; Monica Taljaard, PhD ; Jessica Ogarek, MS ; Lisa Han, MPH ; Roshani Dahal, MPH ; Pedro Gozalo, PhD ; Vincent Mor, PhD
Preparedness for and Response to Meningococcal Outbreaks:Safety Results of a Randomized Controlled Trial of Two Schedules of 4CMenB Vaccine in Adolescents and Young Adults
Joanne M. Langley, MD, FRCPC, FSHEA ; Soren Gantt, MD, PhD ; Caroline Quach, MD, MSc, FRCPC, FSHEA ; Joenel Alcantara, PhD ; Julie a. Bettinger, PhD ; Scott Halperin, MD ; Brian J. Ward, MD ; Shelly Mcneil, MD, FRCPC, FIDSA ; Jill Mutch, BScN ; Donna Mackinnon-Cameron, MMath ; Kim Marty, BSc ; David Scheifele, MD
A Global Phase 3 Study of Delafloxacin (DLX) Compared to Vancomycin/Aztreonam (VAN/AZ) in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
W O' Riordan, MD ; Alison Mc Manus, DNP, FNP-BC, CPI ; Juri Teras, MD, FACS ; Ivan Poromanski, MD, PhD ; Maria Cruz Saldariagga, MD ; Megan Quintas, BS ; Laura Lawrence, B.S. ; Sue K. Cammarata, M.D.
Efficacy And Safety Of Procalcitonin-Guided-Decision Making In Neonates Suspected Of Early Onset Sepsis: The Neopins Study - An International, Multicenter Non-inferiority Randomized Controlled Intervention Trial.
Wendy Van Herk, MD ; Martin Stocker, MD ; Salhab El Helou, MD ; Matteo Fontana, MD ; Frank a.B.a. Schuerman, MD ; H.K. Van Den Tooren, MD ; Jantien Bolt, MD ; Jan Janota, MD ; Laura H. Van Der Meer, MD ; Rob Moonen, MD ; Sintha D. Sie, MD PhD ; Esther De Vries, MD ; Albertine Donker, MD ; Urs Zimmermann, MD ; Luregn G. Schlapbach, MD PhD ; Amerik C. De Mol, MD PhD ; Angelique Haringsma, MD ; Roy Madan, MD ; Maren Tomaske, MD ; Rene F. Kornelisse, MD PhD ; Juliette Van Gijsel, MD ; Eline G. Visser, Drs ; Sten P. Willemsen, Drs ; Wim Hop, Ir ; Annemarie M.C. Van Rossum, MD, PhD
Safety and Pharmacokinetics (PK) of the Respiratory Syncytial Virus (RSV) Polymerase Inhibitor, ALS-8176, in Otherwise Healthy Infants Hospitalized with Acute RSV Infection
Adam Finn, MD, PhD ; Michael Fayon, MD PhD ; Jolanta Bernatoniene, MD PhD ; Kathia Luciani, MD ; Rattapon Uppala, MD ; John Fry, BS, RGN ; Sushmita Chanda, PhD ; Patrick Smith, PharmD Candidate ; Keith Nieforth, PhD ; Kashyap Patel, PhD ; Abbie Oey, BA ; Julian Symons, D. Phil. ; Qingling Zhang, PhD ; Lawrence Blatt, PhD ; Leonid Beigelman, PhD ; Matthew Mcclure, MD
Dexamethasone for Parapneumonic Pleural Effusion in Children: A Randomized, Double-Blind, Phase II, Clinical Trial.
Alfredo Tagarro, MD, PhD ; Enrique Otheo, MD ; Fernando Baquero-Artigao, MD ; Maria-Luisa Navarro, Ph.D., M.D. ; Rosa Velasco, MD ; Maria Penin, Ph.D., M.D. ; David Moreno, Ph.D., M.D. ; Pablo Rojo, Ph.D., M.D.
The Antiseptic Scrub Contamination and Transmission (ASCOT) Trial: a 3-Arm Cluster-Randomized Controlled Crossover Trial to Determine the Impact of Antiseptic-Impregnated Scrubs on Healthcare Worker Contamination
Deverick Anderson, MD, MPH, FIDSA, FSHEA ; Rachel Addison, MT (ASCP), MPH ; Yuliya Lokhnygina, MS, PhD ; Sarah S. Lewis, MD MPH ; Rebekah W. Moehring, MD, MPH ; David J. Weber, MD, MPH, FIDSA, FSHEA ; William a. Rutala, PhD, MPH ; Daniel J. Sexton, MD, FIDSA, FSHEA
A Randomized Multicenter Study of Daptomycin Versus Standard of Care in Pediatric Subjects with Bacteremia Caused by Staphylococcus aureus
Antonio Arrieta, MD, FIDSA ; John S. Bradley, MD, FIDSA, FPIDS ; Myra W. Popejoy, PharmD ; Mekki Bensaci, PhD, MSc ; Anjana Grandhi, PhD ; Nicholas Kartsonis, MD
Colonization of Probiotics in Bangladeshi Infants after Different Administration Regimens
Yana Emmy Hoy-Schulz, PhD ; Kaniz Jannat, MBBS ; Thomas Roberts, BS ; Saira Zaidi, MPH ; Md. Mostafizur Rahman, BS ; Leanne Unicomb, PhD ; Stephen Luby, MD ; Julie Parsonnet, MD, FIDSA
Safety and tolerability of 514G3, a True Human Anti-Protein A Monoclonal Antibody for the treatment of S. aureus Bacteremia.
Toan Huynh, MD ; Michael Stecher, MD ; John Mckinnon, MD, MSc ; Norma Jung, MD ; Mark E. Rupp, MD, FIDSA, FSHEA
Posters
  • 1354_IDWPOSTER.pdf (8.1 MB)
  • A Pilot Randomized Controlled Trial of Adjuvanted vs. Nonadjuvanted Influenza vaccine in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients
    Yoichiro Natori, MD ; Atul Humar, MD ; Jeffrey Lipton, MD ; Dennis Kim, MD ; Katja Hoschler, PhD ; Peter Ashton, MSc ; Deepali Kumar, MD
    Cranberry Capsules for Reduction of Bacteriuria Plus Pyuria in Nursing Home Women: A Randomized Clinical Trial
    Manisha Juthani-Mehta, MD, FIDSA, FSHEA ; Peter Van Ness, PhD, MPH ; Luann Bianco, BA ; Andrea Rink, RN ; Sabina Rubeck, MPH ; Sandra Ginter, RN ; Stephanie Argraves, MS ; Peter Charpentier, MPH ; Denise Acampora, MPH ; Mark Trentalange, MD, MPH ; Vincent Quagliarello, MD, FIDSA ; Peter Peduzzi, PhD
    Posters
  • 1356_IDWPOSTER.pdf (548.2 kB)
  • The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials
    John Kokai-Kun, PhD ; Tracey Roberts, BSN ; Eric Sicard, MD ; Marianne Rufiange, PhD, PMP ; Richard Fedorak, MD ; Christian Carter, PhD ; Olivia Coughlin, PhD ; Heidi Whalen, MHS ; Klaus Gottlieb, MD ; Joseph Sliman, MD, PhD
    Posters
  • IDWeek-2016 Poster.pdf (954.8 kB)
  • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.